ReviewCell communication and signaling : CCS2025
Role of DEAD/DEAH-box helicases in immunity, infection and cancers.
Review in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- DHX15 as a novel immune-related prognostic biomarker in breast cancer: An integrated bioinformatics analysis withOncology letters · 2026Article
- DHX37 protein and mRNA expression patterns in breast and ovarian cancer and their prognostic implications.Histochemistry and cell biology · 2026Article
- Role of DDX39A in modulating the tumor progression and radiosensitivity in esophageal squamous cell carcinoma.Cellular oncology (Dordrecht, Netherlands) · 2026Article
- The rice DEAD-box RNA helicase OseIF4AIIa associates with the CCR4-NOT complex and exhibits stress-responsive expression.Molecular biology reports · 2026Article
- DDX10 RNA Helicase: Structure, Function, and Oncogenic Roles Across Solid and Hematologic Tumors.Genes · 2026Review
- Molecular grammars of predicted intrinsically disordered regions that span the human proteome.Cell · 2026Article
- Structural and functional perspectives on DEAD-box RNA helicases in the rubber tree cold stress response.Frontiers in plant science · 2026Review
- Identification of Novel TAT-I24-Related Peptides with Antiviral Activities.International journal of molecular sciences · 2025Article
- DDX1 facilitates lenvatinib resistance in hepatocellular carcinoma through regulating ephrin-A3 and activating the Wnt/β-catenin signaling pathway.Functional & integrative genomics · 2025Article
- Using Whole Exome Sequencing to Identify Genetic Causes of Neurodevelopmental Disorders in a Cohort of 11 Patients: A Single Center Experience.International journal of molecular sciences · 2025Article
- Ddx3xa mutations drive cardiac defects in a zebrafish model via dysregulation of wnt/β-catenin signaling.Frontiers in molecular biosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DEAD/DEAH-box helicases (DDX) are integral RNA-binding proteins within the RNA helicase superfamily 2 (SF2), characterized by distinct DEAD (Asp-Glu-Ala-Asp) and DEAH (Asp-Glu-Ala-His) motifs. These motifs delineate two subfamilies: DEAD-box (DDX) and DEAH-box (DHX). DEAD-box proteins predominantly facilitate localized non-processive RNA duplex destabilization, whereas DEAH-box helicases mediate processive RNA translocation and unwinding. This functional dichotomy is attributed to Asp-to-His substitution in the DEAH motif, which modulates ATP hydrolysis and conformational dynamics. DEAD-box helicases have been implicated in critical cellular processes, including translation, splicing, and RNA decay. In contrast, DEAH-box proteins play pivotal roles in splicing, ribosome biogenesis, and RNA export. DEAD/DEAH-box helicases play crucial roles in various cellular processes, and their regulation is primarily governed by post-translational modifications (PTMs) and protein-protein interactions (PPIs), particularly within their N- and C-terminal sequences. Despite extensive research, significant knowledge gaps persist regarding their regulation, cofactor roles, substrates, PPIs, mutation effects, and involvement in signaling cascades. Mutations in DEAD domains have been associated with dysregulated immune signaling and have been implicated in various cancers, underscoring their importance in disease pathogenesis. Specific helicases, including DDX3, DDX5, DDX6, and DDX41, have been extensively studied for their roles in immune response regulation, antiviral defense, and cellular stress response. This review critically examines the DEAD-box helicases involved in cell cycle regulation and their inhibitors, as well as those that regulate the Toll-like receptor signaling pathway. Furthermore, we provide comprehensive insights into the phosphorylation-based regulation of major DDX members, with a particular focus on DDX3X, DDX21, and DDX42 in various cancers. Elucidating the molecular mechanisms, regulatory influences, and therapeutic potential of DEAD/DEAH-box helicases is of paramount importance, particularly in the fields of infectious diseases and immune modulation. This review provides current knowledge and identifies critical areas for future research, aiming to advance our understanding of these essential molecular machines and their potential as therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.